Investing in Co-Diagnostics, Inc. (CODX)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)11342.31945092
Intrinsic value (DCF)3.53194
Graham-Dodd Method0.54-55
Graham Formula17.861388

Company description

Co-Diagnostics, Inc. is a molecular diagnostics company based in Salt Lake City, Utah, with operations in Europe, India, and the United States, that specializes in developing, manufacturing, and marketing innovative molecular diagnostic tests. The company's ticker symbol is CODX, and it is traded on the Nasdaq Stock Exchange. Co-Diagnostics focuses on creating rapid, accurate, and cost-effective polymerase chain reaction (PCR) diagnostic tests for a variety of applications, including infectious diseases, women's health, vector-borne diseases, and agriculture. The company's proprietary technology, CoPrimers™, allows for highly specific and sensitive detection of target genetic material, making it a valuable tool for disease diagnosis and monitoring. Co-Diagnostics has received numerous awards and recognitions for its cutting-edge technology and innovative products. With a strong team of experienced scientists and dedicated professionals, the company is committed to improving global health outcomes through its advanced diagnostic tests.